T. Bragg
Howard Hughes Medical Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by T. Bragg.
Genomics | 1988
Mark Lathrop; Yusuke Nakamura; Peter Cartwright; P. O'Connell; M. Leppert; Carol Jones; Hideo Tateishi; T. Bragg; Jean Marc Lalouel; Ray White
We have constructed a primary genetic map for human chromosome 10 from 13 polymorphic marker systems defining 11 loci, using a new gene mapping algorithm implemented in the computer program GMS. The loci form a continuous genetic map that spans approximately 116 cM in males and 170 cM in females. These loci provide regularly spaced anchor points for linkage studies, except for one interval that is 28 cM in males and 64 cM in females.
Genomics | 1988
Yusuke Nakamura; Mark Lathrop; T. Bragg; M. Leppert; P. O'Connell; Carol Jones; Jean Marc Lalouel; R. White
We have extended, in both directions, our recently published genetic map of markers for human chromosome 10 by the addition of 10 newly defined arbitrary loci. The map now covers 230 cM in males and 329 cM in females. In addition, three new markers, one of them a new RFLP at the IRBP gene locus, have been mapped in the vicinity of the locus responsible for multiple endocrine neoplasia type 2A (MEN2A). A significantly higher frequency of recombination in males than in females was observed near both ends of the new map.
Genomics | 1989
Yusuke Nakamura; Christopher G. Mathew; Hagay Sobol; Easton Df; Telenius H; T. Bragg; K. Chin; J. Clark; Carol Jones; Gilbert M. Lenoir
The inherited cancer syndrome multiple endocrine neoplasia type 2A (MEN2A) has recently been mapped to chromosome 10. We have typed 29 families with this disorder with DNA markers from the pericentromeric region of chromosome 10. Two markers, RBP3 and MCK2, were tightly linked to the MEN2A gene at recombination fractions of less than 3%. Multipoint analysis of the linkage data suggests that the gene is located within a 3-cM interval defined by the markers RBP3/MCK2 on one side and TB14.34 on the other. No evidence for locus heterogeneity was detected in any of the 27 families from 14 countries who were informative for the markers tested. The data confirm and refine the original assignment and provide the basis for presymptomatic screening for this disorder.
Genomics | 1992
Takashi Tokino; Shuya Takiguchi; Akira Tanigami; T. Bragg; Carol Jones; Yusuke Nakamura
Thirty-one new RFLP systems corresponding to 24 loci have been identified from a chromosome 10-specific cosmid library. Twelve of the markers on the proximal long arm (cen-q11.2) of this chromosome, including four RFLP systems for the RET locus, will be especially useful in efforts to identify the gene responsible for multiple endocrine neoplasia type 2A (MEN2A). The new panel of markers also may contribute to fine-scale mapping of tumor suppressor genes associated with glioblastoma multiforme or renal cell carcinoma, because allelic deletions in these tumors have implied the presence of a tumor suppressor gene(s) on chromosome 10.
Nucleic Acids Research | 1988
T. Bragg; Yusuke Nakamura; Carol Jones; R. White
Nucleic Acids Research | 1988
T. Bragg; Yusuke Nakamura; E. Fujimoto; P. O'Connell; M. Leppert; G.M. Lathrop; J.-M. Lalouel; R. White
Nucleic Acids Research | 1988
Yusuke Nakamura; T. Bragg; L. Ballard; M. Leppert; P. O'Connell; G.M. Lathrop; J.-M. Lalouel; R. White
Nucleic Acids Research | 1988
T. Bragg; Yusuke Nakamura; Carol Jones; R. White
Nucleic Acids Research | 1988
T. Bragg; Yusuke Nakamura; Carol Jones; R. White
Nucleic Acids Research | 1988
T. Bragg; Yusuke Nakamura; Carol Jones; Ray White